Exploring retinal degenerative diseases through CRISPR-based screening
Molecular Biology Reports · 2024
DOI: 10.1007/s11033-024-09969-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Rui Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan Provincial Key Laboratory for Human Disease Gene Study and the Center for Medical Genetics, Department of Laboratory Medicine, Sichuan Academ…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing, Retinal Degeneration. Die Arbeit nennt 113 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, National Key R&D Program of China, Sichuan Science and Technology Program.
Abstract (Originalsprache)
The CRISPR (Clustered regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated protein9) system has emerged as a powerful genetic tool, gaining global recognition as a versatile and efficient gene-editing technique. Its transformation into a high-throughput research platform, CRISPR Screening, has demonstrated wide applicability across various fields such as cancer biology, virology, and drug target discovery, resulting in significant advances. However, its potential in studying retinal degenerative diseases remains largely unexplored, despite the urgent need for effective treatments arising from an incomplete understanding of disease mechanisms. This review aims to present a comprehensive overview of the evolution and current state of CRISPR tools and CRISPR screening methodologies. Noteworthy pioneering studies utilizing these technologies are discussed, alongside experimental design guidelines, including positive and negative selection strategies and delivery methods for sgRNAs (single guide RNAs) and Cas proteins. Furthermore, we explore existing in vitro models appropriate for CRISPR screening in retinal research and identify relevant research questions that could be addressed through this approach. It is anticipated that this review will stimulate innovation in retinal research, facilitating a deeper comprehension of retinal pathophysiology and paving the way for groundbreaking therapeutic interventions and enhanced patient outcomes in the management of retinal degenerative disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sichuan Provincial Key Laboratory for Human Disease Gene Study and the Center for Medical Genetics, Department of Laboratory Medicine, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Univer…
- School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
- School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. jinghu_somed@uestc.edu.cn.
- Research Unit for Blindness Prevention, Chinese Academy of Medical Sciences (2019RU026), Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan, China. jinghu_somed@uestc.edu.cn.
- School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. qianhao@uestc.edu.cn.
- Research Unit for Blindness Prevention, Chinese Academy of Medical Sciences (2019RU026), Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan, China. qianhao@uestc.edu.cn.
Förderung
- the National Natural Science Foundation of China
- National Key R&D Program of China
- Sichuan Science and Technology Program
Zitieren
APA
Li, R., Yang, F., Chu, B., Kong, D., Hu, J., & Qian, H. (2024). Exploring retinal degenerative diseases through CRISPR-based screening. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09969-6
Vancouver
Li R, Yang F, Chu B, Kong D, Hu J, Qian H. Exploring retinal degenerative diseases through CRISPR-based screening. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09969-6
BibTeX
@article{Li2024,
author = {Li, Rui and Yang, Fengming and Chu, Boling and Kong, Dehua and Hu, Jing and Qian, Hao},
title = {Exploring retinal degenerative diseases through CRISPR-based screening},
journal = {Molecular Biology Reports},
year = {2024},
doi = {10.1007/s11033-024-09969-6}
}
EUVIMED